Circulating Biomarkers World Congress 2019 (San Diego, CA,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
46
Circulating Biomarkers World Congress 2019 (San Diego, CA, United States - March 27-29, 2019)

Dublin, Feb. 08, 2019 (GLOBE NEWSWIRE) -- The "Circulating Biomarkers World Congress 2019" conference has been added to ResearchAndMarkets.com's offering.

This Annual Circulating Biomarkers World Congress 2019 brings together the most up-to-date technologies and advances in this expanding and evolving field.

The coverage of this conference focuses on the various classes of circulating biomarkers and their emerging applications:

  • Extracellular Vesicles (EVs): Exosomes and Microvesicles
  • Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
  • Circulating Cells in the Circulation (Circulating Tumor Cells and Cancer Stem Cells)

This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas:

  • Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
  • Role in Cancer and Various Disease Classes
  • Biomarker Potential for Diagnostics Development
  • Therapeutics Potential and Technology Advances in the EV Field

Agenda:

DAY 1 - WEDNESDAY, 27 MARCH 2019 08:00 - Conference Registration, Materials Pick-Up, Morning Coffee and Breakfast Pastries 08:45 - Conference Chair

  • Conference Co-Chairperson Opening Remarkers and Welcome to Delegates
  • Paul Robbins, Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School, United States of America
  • Session Title: Conference Plenary Session -- Emerging Themes in Circulating Biomarkers and Liquid Biopsies
  • Plenary Session Chairperson: Lucia R. Languino, Ph.D., Professor of Cancer Biology, Thomas Jefferson University

09:00 - Keynote Presentation

  • Mt-SEA Pipeline: High Throughput Flow Cytometric Analysis of Exosomes in Clinical Biofluids
  • Jennifer Jones, Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI), United States of America

09:30 - Keynote Presentation

  • Disease-Specific Vascular Markers for Cancer, Atherosclerosis and Brain Diseases
  • Erkki Ruoslahti, Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute, United States of America

10:00 - Coffee Break and Networking in the Exhibit Hall 10:45 - Keynote Presentation

  • Precision Medicine Using Liquid Biopsies: A New Paradigm for Managing Cancer Diseases
  • Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology, United States of America

11:15 - Conference Chair

  • Exosomes: Novel Opportunities for the Diagnosis and Therapy of Cancer
  • Lucia Languino, Professor of Cancer Biology, Thomas Jefferson University, United States of America

11:45 - Keynote Presentation

  • Tumor-derived Exosomes Contribute to a Pro-inflammatory Tumor Microenvironment through the Stimulation of Chemokines and Cytokines in Mesenchymal Stromal Cells and Macrophages
  • Yves A. DeClerck, Professor of Pediatrics and Biochemistry & Molecular Medicine, Children's Hospital Los Angeles, University of Southern California, United States of America

12:15 - Networking Lunch in the Exhibit Hall and Poster Viewing

  • Session Title: Intercellular Communication Mediated by Exosomes/EVs - An Emerging Class of Circulating Biomarkers

14:00 - Cancer-Host Crosstalk Through Exosomal miRNA

  • Shizhen Emily Wang, Associate Professor, Department of Pathology, University of California, San Diego, United States of America

14:30 - Nanodiagnostic Tool for Comprehensive Assessment of Cancer in Blood

  • Shan Wang, Leland T. Edwards Professor in the School of Engineering, Stanford University, United States of America

15:00 - Modulation of Extracellular Vesicle Release and Content in SCC Cells

  • My Mahoney, Professor and Vice Chair, Thomas Jefferson University, United States of America

15:30 - Coffee Break and Networking in the Exhibit Hall 16:30 - A Novel Extracellular Vesicle Isolation Method Used to Discover Urine Liver Disease Candidate Biomarkers

  • Shannon Pendergrast, Chief Scientific Officer, Ymir Genomics, United States of America

17:00 - Particle Metrix GmbHEV Biomarker Detection using Particle Metrix ZetaView Instruments and Fluorescent Nanoparticle Tracking Analysis (F-NTA)

  • Sven Rudolf Kreutel, General Sales Manager, Particle Metrix GmbH

17:30 - NanoFCMNano-Flow Cytometry: Next-Generation Platform for Comprehensive EV Analysis

  • Dimitri Aubert, VP Sales and Marketing, Managing Director Europe, NanoFCM

18:00 - Networking Reception with Beer and Wine in the Exhibit Hall 19:00 - Close of Day 1 of the Conference. DAY 2 - THURSDAY, 28 MARCH 2019 08:00 - Morning Coffee Break and Breakfast Pastries Served in the Exhibit Hall

  • Session Title: Microfluidics Technologies for Circulating Biomarkers Analysis

08:30 - Silicon Chip Nanofluidics for Extracellular Vesicle Enrichment

  • Benjamin H. Wunsch, Research Staff Member, T.J. Watson Research Center, IBM, United States of America

09:00 - Keynote Presentation

  • NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
  • Hsian-Rong Tseng, Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles, United States of America

09:30 - Keynote Presentation

  • Rapid Simultaneous Isolation and Detection of Exosome/EV and cfDNA Biomarkers from Cancer Patient Blood Samples
  • Michael Heller, Distinguished Scientist - Knight Cancer Institute at Oregon Health & Science University (OHSU), Center for Cancer Early Detection and Research (CEDAR); Professor, University of California-San Diego, United States of America

10:00 - Keynote Presentation

  • Chemistry-Free Microfluidic Technologies to Sort Cells for Health and Disease
  • Utkan Demirci, Professor, Stanford University School of Medicine, United States of America

10:30 - Coffee Break and Networking in the Exhibit Hall 12:00 - Networking Lunch in the Exhibit Hall and Poster Viewing 12:30 - Afternoon Session Presentations in the EV Summit Track 17:30 - Industry Panel Discussion Focusing on Circulating Biomarkers & Liquid Biopsy 18:15 - Close of Day 2 of the Conference Track DAY 3 - FRIDAY, 29 MARCH 2019 08:30 - Morning Coffee and Breakfast Pastries Served in the Exhibit Hall 09:30 - Identification and Characterization of Circulating Long Non-Coding RNAs and HPV16/18 Cell-Free DNA as Cancer Biomarkers from Serum of Cervical Cancer Patients

  • Tawin Lempridee, Researcher, National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency, Thailand
  • Circulating lncRNAs and HPV16/18 E7 ctDNA may be used as cancer biomarkers for developing a blood-based cervical cancer screening test.

10:00 - exRNA Biomarkers: Challenges in Methodology

  • Srimeenakshi Srinivasan, Research Fellow, University of California, San Diego, United States of America

Speakers

Conference Chairs:

Lucia R. Languino

  • Professor of Cancer Biology, Thomas Jefferson University

Paul Robbins

  • Professor of Molecular Medicine, University of Minnesota Medical School

Keynote Speakers: Steve Soper

  • Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology

Hsian-Rong Tseng

  • Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles

Erkki Ruoslahti

  • Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute

Utkan Demirci

  • Professor, Stanford University School of Medicine

Yves A. DeClerck

  • Professor of Pediatrics and Biochemistry & Molecular Medicine, Children's Hospital Los Angeles, University of Southern California

Michael Heller

  • Distinguished Scientist - Knight Cancer Institute at Oregon Health & Science University (OHSU), Center for Cancer Early Detection and Research (CEDAR); Professor, University of California-San Diego

Jennifer Jones

  • Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI)

For more information about this conference visit https://www.researchandmarkets.com/research/9...ating?w=12

About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biomarkers

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 145

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Partner Joins Yardi ICN, Boosting Data Quality for Clients

Updated Category News Views 91

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 61

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 101

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 70

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 156

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 46

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 215

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 170

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading

Top 5 Most Recently Viewed Articles

Cresilon Expands Reach with New VETIGEL Deal for Veterinarians

Updated Category News Views 267

Cresilon Partners with McCarthy Vet to Distribute VETIGEL Cresilon Inc., an innovative biotechnology firm known for its advanced hemostatic products, has announced a transformative agreement with McCarthy Vet. This collaboration marks a significant step forward as it allows for the distribution of VETIGEL, a groundbreaking hemostatic gel, directly to veterinary surgeons....

Continue Reading
Absci's Upcoming Financial Report and Business Highlights

Updated Category News Views 192

Absci Corporation's Upcoming Financial Reports Absci Corporation (Nasdaq: ABSI), recognized as a pioneer in data-driven generative AI for drug discovery, is gearing up to release important business updates along with financial results for the first quarter of 2025. This report is scheduled to be unveiled subsequent to market close. Key Highlights of the Upcoming Report...

Continue Reading
Upcoming Q2 2025 Results Announcement by Borregaard ASA

Updated Category News Views 186

Borregaard ASA's Second Quarter Results Announcement Borregaard ASA, a renowned name in biochemistry, is set to present its Q2 2025 results. This event will take place on Wednesday, coinciding with July 16, 2025, at 07:00 CEST. As anticipated, a comprehensive stock exchange announcement will follow shortly thereafter. What to Expect from the Presentation The presentation...

Continue Reading
JP Conte's Lupine Crest Pours $14M into Orizon Again

Updated Category News Views 29

JP Conte's Bet on Brazilian Waste-to-Energy Giant Here's the scoop, folks. Lupine Crest Capital, helmed by none other than JP Conte, just doubled down on their investment in Brazil. This isn't some negligible penny-ante increase, but a hefty infusion of R$70 million—think roughly $14 million in USD—into Orizon Valorização de Resíduos S.A., the notable...

Continue Reading
Hedge Funds Shift Strategies Amid Volatile U.S. Equity Markets

Updated Category News Views 121

Hedge funds adjusted their playbooks back then in 2023, net selling equities amid a flurry of options expiry and index rebalancing. The desks were abuzz as they noted slight selling pressure from these funds, yet after the dust settled on that chaotic week, buying picked up noticeably—especially Thursday when it seemed traders found some footing again. Macro Products...

Continue Reading